Medtronic Stock News

Medtronic (MDT) delivered earnings and revenue surprises of 0.74% and 1.60%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

The surgical supply store reported third-quarter earnings on Tuesday, saying foreign exchange impacts could take a chunk off of top line earnings.

Medtronic (MDT) is trading flat in the pre-market on Tuesday after the company reported lower-than-expected revenue for Q3 fiscal 2022 and set its guidance for the current quarter in

Medtronic plc (MDT) CEO Geoff Martha on Q3 2022 Results - Earnings Call Transcript

Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.

Medtronic said Tuesday it expects procedure volumes in most of its markets to be back to pre-COVID level by the end of the fourth quarter. The medical device maker said its third-quarter net income rose 17% to $1.48 billion, or $1.10 a share, from $1.27 billion, or 94 cents a share, in the year-ago quarter. Adjusted earnings in the latest quarter were $1.37 per share, up 6%. Third-quarter revenue dipped 0.2% to $7.76 billion. The company fell a penny short of the Wall Street consensus estimate of $1.38 a share, and missing the revenue target of $7.95 billion, according to FactSet data. Looking ahead, Medtronic expects fourth-quarter adjusted earnings of $1.56 to $1.58 share, which includes a neutral to slightly positive impact from foreign currency, against a Wall Street estimate of $1.57 a share. CEO Geoff Martha said Medtronic expects healthcare procedures to reaccelerate post-Omicron. Shares of Medtronic rose 0.5% in premarket trades. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

Medtronic Plc reported a 16.5% rise in quarterly profit on Tuesday, as strong demand for its heart devices cushioned weakness in some other businesses during the Omicron-led surge in COVID-19 infections.

Medtronic (MDT) delivered earnings and revenue surprises of 0.74% and 1.60%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

Medtronic's (MDT) Cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT.

Medtronic MDT, -1.10% said Tuesday it expects procedure volumes in most of its markets to be back to pre-COVID level by the end of the fourth quarter. The medical device maker said its third-quarter n

Three digital health stocks are moving the needle for the fast-growing telehealth business. Let's have a look at TDOC, MDT and BFLY.

DUBLIN--(BUSINESS WIRE)--The "Global Surgical Robots Market" report has been added to ResearchAndMarkets.com''s offering. The global surgical robots market was valued at $8052.67 Million in the year 2020 with North America region leading the regional market share. Companies Mentioned Intuitive Surgical Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Accuray Incorporated Renishaw Asensus Surgical Medrobotics Corporation Think Surgical The market is projected to display momentous gr

Riding The Stock Waves: Update On The Medical Devices Sector

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the global Artificial Pancreas Device System Market finds that, increasing prevalence of diabetes is expediting market growth. The market growth is attributed to increasing population across the globe as well as lack of precise effective substitute. Total global Artificial Pancreas Device System Market is estimated to reach USD 415.8 Million by 2028. The Market stood at a revenue of USD 95.6 Million in 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.1%. Furthermore, rising demand for automated systems for glycemic control, as well as increasing funding in Research and Development (R&D) is projected to augment growth of the global Artificial Pancreas Device System Market, states Vantage Market Research, in a report, titled " Artificial Pancreas Device System Market by Device (Threshold Suspended Device System, CTR System, CTT System), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Polen Capital, an investment management firm, published its Polen International Growth fourth quarter 2021 investor letter a copy of which can be downloaded here.